[	(	[ ( NUPOS
Quantifying	VBG	quantify VBG PennPOS
plasma	NN	plasma NN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-beta1	NN	transforming-growth-factor-beta1 NN PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
]	)	] ) NUPOS
.	.	. . NUPOS

OBJECTIVE	NN	objective NN PennPOS
:	:	: : NUPOS
Transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
ss1	NN	ss1 NN PennPOS
(	(	( ( NUPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
one	CD	one crd NUPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
key	JJ	key JJ PennPOS
profibrotic	JJ	profibrotic JJ PennPOS
mediators	NNS	mediator NNS PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
purpose	NN	purpose NN PennPOS
of	IN	of pp-f NUPOS
this	DT	this d NUPOS
study	NN	study NN PennPOS
was	VBD	be vbd NUPOS
to	TO	to p-acp NUPOS
investigate	VB	investigate VBP PennPOS
the	DT	the dt NUPOS
prognostic	JJ	prognostic JJ PennPOS
value	NN	value NN PennPOS
of	IN	of pp-f NUPOS
quantifying	VBG	quantify VBG PennPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
levels	NNS	level NNS PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

PATIENTS	NNS	patient NNS PennPOS
AND	CC	and cc NUPOS
METHODS	NNS	method NNS PennPOS
:	:	: : NUPOS
We	PRP	we pns12 NUPOS
conducted	VBD	conduct VBD PennPOS
a	DT	a dt NUPOS
prospective	JJ	prospective JJ PennPOS
study	NN	study NN PennPOS
of	IN	of pp-f NUPOS
29	CD	29 CD PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
27	CD	27 crd NUPOS
healthy	JJ	healthy JJ PennPOS
controls	NNS	control NNS PennPOS
.	.	. . NUPOS

Enzyme-linked	JJ	enzyme-linked JJ PennPOS
immunosorbent	JJ	immunosorbent JJ PennPOS
assays	NNS	assay n2 NUPOS
were	VBD	be vbd NUPOS
used	VBN	use VBN PennPOS
to	TO	to p-acp NUPOS
quantify	VB	quantify VBP PennPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
levels	NNS	level NNS PennPOS
.	.	. . NUPOS

RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
Mean	NN	mean NN PennPOS
(	(	( ( NUPOS
SD	NN	sd NN PennPOS
)	)	) ) NUPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
levels	NNS	level NNS PennPOS
were	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
higher	JJR	high JJR PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
than	IN	than cs NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
control	JJ	control JJ PennPOS
subjects	NNS	subject NNS PennPOS
(	(	( ( NUPOS
11.1	CD	11.1 CD PennPOS
[	(	[ ( NUPOS
7.5	CD	7.5 CD PennPOS
]	)	] ) NUPOS
ng/mL	NN	ng/mL NN PennPOS
vs	CC	vs CC PennPOS
4	CD	4 crd NUPOS
[	(	[ ( NUPOS
2.4	CD	2.4 CD PennPOS
]	)	] ) NUPOS
ng/mL	NN	ng/mL NN PennPOS
;	:	; : NUPOS
P	NN	p NN PennPOS
<	JJR	< JJR PennPOS
.01	CD	.01 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Weak	JJ	weak JJ PennPOS
inverse	JJ	inverse JJ PennPOS
correlations	NNS	correlation NNS PennPOS
were	VBD	be vbd NUPOS
observed	VBN	observe VBN PennPOS
between	IN	between IN PennPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
levels	NNS	level NNS PennPOS
and	CC	and cc NUPOS
both	CC	both CC PennPOS
forced	VBD	force VBD PennPOS
vital	JJ	vital JJ PennPOS
capacity	NN	capacity NN PennPOS
and	CC	and cc NUPOS
total	JJ	total JJ PennPOS
lung	NN	lung NN PennPOS
capacity	NN	capacity NN PennPOS
.	.	. . NUPOS

Thirteen	CD	thirteen crd NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
were	VBD	be vbd NUPOS
evaluated	VBN	evaluate VBN PennPOS
at	IN	at pp NUPOS
8	CD	8 crd NUPOS
(	(	( ( NUPOS
1.2	CD	1.2 CD PennPOS
)	)	) ) NUPOS
months	NNS	month NNS PennPOS
(	(	( ( NUPOS
range	NN	range NN PennPOS
,	,	, , NUPOS
5-9	CD	5-9 CD PennPOS
months	NNS	month NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
mean	NN	mean NN PennPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
level	NN	level NN PennPOS
was	VBD	be vbd NUPOS
18.2	CD	18.2 CD PennPOS
(	(	( ( NUPOS
15	CD	15 crd NUPOS
)	)	) ) NUPOS
ng/mL	NN	ng/mL NN PennPOS
and	CC	and cc NUPOS
there	EX	there pc-acp NUPOS
were	VBD	be vbd NUPOS
no	DT	no dx NUPOS
significant	JJ	significant JJ PennPOS
differences	NNS	difference NNS PennPOS
with	IN	with pp NUPOS
respect	NN	respect NN PennPOS
to	TO	to p-acp NUPOS
the	DT	the dt NUPOS
initial	JJ	initial JJ PennPOS
measurement	NN	measurement NN PennPOS
of	IN	of pp-f NUPOS
11.1	CD	11.1 CD PennPOS
(	(	( ( NUPOS
7.5	CD	7.5 CD PennPOS
)	)	) ) NUPOS
ng/mL	NN	ng/mL NN PennPOS
.	.	. . NUPOS

No	DT	no dx NUPOS
correlation	NN	correlation NN PennPOS
was	VBD	be vbd NUPOS
observed	VBN	observe VBN PennPOS
between	IN	between IN PennPOS
changes	NNS	change NNS PennPOS
in	IN	in IN PennPOS
respiratory	JJ	respiratory JJ PennPOS
function	NN	function NN PennPOS
and	CC	and cc NUPOS
changes	NNS	change NNS PennPOS
in	IN	in IN PennPOS
TGF-ss1	NN	TGF-ss1 NN PennPOS
levels	NNS	level NNS PennPOS
.	.	. . NUPOS

CONCLUSIONS	NNS	conclusion NNS PennPOS
:	:	: : NUPOS
Although	IN	although cs NUPOS
plasma	NN	plasma NN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
were	VBD	be vbd NUPOS
high	JJ	high JJ PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
they	PRP	they pns31 NUPOS
do	VBP	do vdb NUPOS
not	RB	not xx NUPOS
appear	VB	appear VBP PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
a	DT	a dt NUPOS
useful	JJ	useful JJ PennPOS
prognostic	JJ	prognostic JJ PennPOS
marker	NN	marker NN PennPOS
of	IN	of pp-f NUPOS
disease	NN	disease NN PennPOS
activity	NN	activity NN PennPOS
or	CC	or cc NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
response	NN	response NN PennPOS
.	.	. . NUPOS

